K070009 is an FDA 510(k) clearance for the AT HOME DRUG TEST MODELS, 9308T AND 9308X. Classified as Enzyme Immunoassay, Barbiturate (product code DIS), Class II - Special Controls.
Submitted by Phamatech, Inc. (San Diego, US). The FDA issued a Cleared decision on December 7, 2007 after a review of 338 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3150 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.